130 related articles for article (PubMed ID: 35084834)
1. Glycopolymer Nanoparticles with On-Demand Glucose-Responsive Insulin Delivery and Low-Hypoglycemia Risks for Type 1 Diabetic Treatment.
Fu Y; Sun Y; Chen M; Xing W; Xu Y; Qian X; Zhu W
Biomacromolecules; 2022 Mar; 23(3):1251-1258. PubMed ID: 35084834
[TBL] [Abstract][Full Text] [Related]
2. On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks.
Fu Y; Liu P; Chen M; Jin T; Wu H; Hei M; Wang C; Xu Y; Qian X; Zhu W
J Colloid Interface Sci; 2022 Jan; 605():582-591. PubMed ID: 34343731
[TBL] [Abstract][Full Text] [Related]
3. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
[TBL] [Abstract][Full Text] [Related]
4. Insulin Granule-Loaded MicroPlates for Modulating Blood Glucose Levels in Type-1 Diabetes.
Primavera R; Bellotti E; Di Mascolo D; Di Francesco M; Wang J; Kevadiya BD; De Pascale A; Thakor AS; Decuzzi P
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53618-53629. PubMed ID: 34751556
[TBL] [Abstract][Full Text] [Related]
5. Glucose-responsive nanoparticles designed via a molecular-docking-driven method for insulin delivery.
Shen D; Yu H; Wang L; Feng J; Zhang Q; Pan J; Han Y; Ni Z; Liang R; Uddin MA
J Control Release; 2022 Dec; 352():527-539. PubMed ID: 36341933
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M
Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176
[TBL] [Abstract][Full Text] [Related]
7. Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.
Wang J; Wang Z; Chen G; Wang Y; Ci T; Li H; Liu X; Zhou D; Kahkoska AR; Zhou Z; Meng H; Buse JB; Gu Z
ACS Nano; 2021 Mar; 15(3):4294-4304. PubMed ID: 33685124
[TBL] [Abstract][Full Text] [Related]
8. A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery.
Wang J; Wang Z; Yu J; Zhang Y; Zeng Y; Gu Z
Biomater Sci; 2019 Nov; 7(11):4508-4513. PubMed ID: 31608343
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention.
GhavamiNejad A; Lu B; Samarikhalaj M; Liu JF; Mirzaie S; Pereira S; Zhou L; Giacca A; Wu XY
Drug Deliv Transl Res; 2022 Apr; 12(4):792-804. PubMed ID: 33683625
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery.
He M; Yu P; Hu Y; Zhang J; He M; Nie C; Chu X
ACS Appl Mater Interfaces; 2021 May; 13(17):19648-19659. PubMed ID: 33890785
[TBL] [Abstract][Full Text] [Related]
11. Glycopolypeptide Nanocarriers Based on Dynamic Covalent Bonds for Glucose Dual-Responsiveness and Self-Regulated Release of Insulin in Diabetic Rats.
Wang Y; Fan Y; Zhang M; Zhou W; Chai Z; Wang H; Sun C; Huang F
Biomacromolecules; 2020 Apr; 21(4):1507-1515. PubMed ID: 32129603
[TBL] [Abstract][Full Text] [Related]
12. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
13. H
Hu X; Yu J; Qian C; Lu Y; Kahkoska AR; Xie Z; Jing X; Buse JB; Gu Z
ACS Nano; 2017 Jan; 11(1):613-620. PubMed ID: 28051306
[TBL] [Abstract][Full Text] [Related]
14. A step towards glucose control with a novel nanomagnetic-insulin for diabetes care.
Yin R; Qian X; Kang L; Wang K; Zhang H; Yang SM; Zhang W
Int J Pharm; 2021 May; 601():120587. PubMed ID: 33845153
[TBL] [Abstract][Full Text] [Related]
15. Nitrilotriacetic Acid-Functionalized Glucose-Responsive Complex Micelles for the Efficient Encapsulation and Self-Regulated Release of Insulin.
Li C; Huang F; Liu Y; Lv J; Wu G; Liu Y; Ma R; An Y; Shi L
Langmuir; 2018 Oct; 34(40):12116-12125. PubMed ID: 30212220
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
Zhao X; Shi A; Ma Q; Yan X; Bian L; Zhang P; Wu J
J Nanobiotechnology; 2021 Jun; 19(1):191. PubMed ID: 34176494
[TBL] [Abstract][Full Text] [Related]
17. Glucose- and temperature-sensitive nanoparticles for insulin delivery.
Wu JZ; Williams GR; Li HY; Wang D; Wu H; Li SD; Zhu LM
Int J Nanomedicine; 2017; 12():4037-4057. PubMed ID: 28603417
[TBL] [Abstract][Full Text] [Related]
18. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
[TBL] [Abstract][Full Text] [Related]
19. Phenylboronate-diol crosslinked glycopolymeric nanocarriers for insulin delivery at physiological pH.
Guo Q; Wu Z; Zhang X; Sun L; Li C
Soft Matter; 2014 Feb; 10(6):911-20. PubMed ID: 24835766
[TBL] [Abstract][Full Text] [Related]
20. Blood glucose levels in diabetic patients undergoing hyperbaric oxygen therapy.
Heyboer Iii M; Wojcik SM; Swaby J; Boes T
Undersea Hyperb Med; 2019 Jun-Jul-Aug - Third Quarter; 46(4):437-445. PubMed ID: 31509900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
